WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-07-06528$123.84
$65.39kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-07-061,975$123.74
$244.39kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-07-064,181$122.34
$511.50kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-07-0612,134$121.65
$1.48MSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-07-0620,000$2.94
$58.72kBuy
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-07-063,124$121.67
$380.10kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-07-061,048$122.43
$128.31kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-07-06300$124.94
$37.48kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-07-061,710$124.79
$213.39kSell
Jolanda HoweSVP GLOBAL CONTROLLER2026-07-012,721$120.00
$326.52kSell

1 of 8

MIRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP12.59%7,679,684$877.02MInstitution
Janus Henderson Group PLC11.39%6,945,813$793.21MInstitution
Peter W. Sonsini6.86%4,186,243$478.07MInsider
David M. Mott6.86%4,186,243$478.07MInsider
Joshua Makower6.86%4,186,243$478.07MInsider
Peter J. Barris6.86%4,186,243$478.07MInsider
Patrick J. Heron6.61%4,031,625$460.41MInsider
Blackrock Inc6.31%3,846,530$439.27MInstitution
Frazier Life Sciences IX LP5.85%3,566,912$407.34MInsider
James E. Flynn5.32%3,244,434$370.51MInsider

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM56.49%43.51%Net BuyingNet Buying
COGT93.06%6.94%Net Selling
CGON85.88%14.12%Net BuyingNet Buying
IBRX16.99%7.30%Net BuyingNet Selling
RYTM88.71%11.29%Net SellingNet Buying
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 111.92% institutional shareholders, 86.22% Mirum Pharmaceuticals insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 6.86% of the company. Peter W. Sonsini's Mirum Pharmaceuticals shares are currently valued at $469.82M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.